Odyssean »

Ultragenyx Pharmaceutical shares owned by Odyssean

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.1M 122k 33.39

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Ultragenyx Pharmaceutical

BlackRock
Vanguard Portfolio Management
State Street Corporation
AQR Capital Management
Vanguard Capital Management
Rtw Investments
Sofinnova Ventures
Sands Capital Management
Wellington Management Company
Bellevue Group
Two Sigma Investments
Frontier Capital Management
Geode Capital Management
Millennium Management
D. E. Shaw & Co

View all funds holding Ultragenyx Pharmaceutical